Physician profile
Blessing Amune
NPI 1760010870
$1,198.08
in general payments reported to CMS, 2019-2025
9 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.14 · 2024: $148 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $249.98 | 2025 | Kisunla |
| Amgen INC. | $167.99 | 2025 | Tepezza |
| Abbott Laboratories | $147.52 | 2024 | Freestyle Libre 3 |
| Alkermes, INC. | $130.00 | 2025 | Lybalvi |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2025 | Airsupra |
| Merck Sharp & Dohme LLC | $124.98 | 2025 | Capvaxive |
| Axsome Therapeutics, INC. | $124.98 | 2025 | Auvelity |
| Novo Nordisk INC | $112.50 | 2025 | Wegovy |
| Eagle Pharmaceuticals, INC. | $15.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blessing Amune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.